2005•Nature Clinical Practice OncologyRequires access
Can plasma Epstein–Barr virus DNA levels be used to monitor nasopharyngeal carcinoma progression?
Paul J. Farrell
Open publisher page 4 citations
Abstract
This record does not include an abstract. Use the full-text link above if available.